ETFs Holding CTIC »    CTIC Historical Stock Prices »
CTIC News Video: Thu, May 22, 2014, 2:43 PM — Thursday's ETF Movers: XBI, EWD

If the video does not load after a few moments, Upgrade to the Latest Flash Player.
CTI BioPharma is a biopharmaceutical company focused on the acquisition, development and commercialization of targeted therapies covering a range of blood-related cancers. Co. focuses on treatments that target blood-related cancers where there is an unmet medical need. In particular, Co. is mainly focused on evaluating pacritinib for the treatment of adult patients with myelofibrosis and the further development of PIXUVRI. PIXUVRI is an aza-anthracenedione which has been granted conditional marketing authorization by the European Commission in the European Union, as a monotherapy for the treatment of adult patients with multiply relapsed or refractory aggressive B-cell non-Hodgkin lymphoma. Self directed investors in CTI BioPharma Corp will be interested in keeping up with all CTI BioPharma Corp news they can find, both CTIC news originating from the company in the form of press releases, as well as seeing how independent media outlets are reporting news on CTIC. At RediNews, we simplify this task by presenting both CTIC news releases originating from CTI BioPharma Corp itself, and CTIC news from a variety of media outlets. Visitors can browse this news online and through our CTIC RSS news feed.


CTIC News — Articles, Videos, & Press Releases

Short Interest In CTI BioPharma Expands By 44.2%
Wednesday, April 10, 2019, 1:02 PM — Market News Video
Short Interest In CTI BioPharma Decreases By 24%
Friday, January 11, 2019, 12:01 PM — Market News Video
Commit To Buy CTI BioPharma Corp At $1, Earn 52.2% Annualized Using Options
Friday, January 4, 2019, 11:32 AM — Stock Options Channel
First Week of CTIC November 16th Options Trading
Tuesday, October 2, 2018, 10:38 AM — Stock Options Channel
Peek Under The Hood: EQWS Has 18% Upside
Thursday, September 27, 2018, 7:54 AM — ETF Channel
Notable Thursday Option Activity: MTZ, KSS, CTIC
Thursday, September 20, 2018, 3:22 PM — Stock Options Channel
Commit To Buy CTI BioPharma Corp At $1, Earn 10.7% Annualized Using Options
Monday, September 10, 2018, 11:45 AM — Stock Options Channel
Short Interest Decreases By 95% For CTIC
Tuesday, July 3, 2018, 12:26 PM — Market News Video
First Week of CTIC July 20th Options Trading
Monday, June 11, 2018, 10:33 AM — Stock Options Channel
CTIC is categorized under the Healthcare sector; below are links to news for some other companies in the same sector:

SSH News
Q News

RediNews invites financial news content websites to integrate our XML content for web sites by integrating our RSS feeds found throughout our website wherever news and stock content is found, by clicking the RSS icon for any news page (which will look like this): . This dynamic content is ideal for any financial portal or web portal, from business content web sites to corporate portal intranets. Let RediNews be your content provider of free financial content for news, perfect for location on stock market chart pages by symbol, adding another element of dynamic stock market content to your financial portal. If your web page content already includes elements like SEC filings, screener pages, historical chart information, and other cobranded financial web content, then headlines from RediNews can supplement this dynamic financial content meaningfully.

CTIC News | | Copyright © 2013 - 2019, All Rights Reserved

Nothing in is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.